Sesen Launches with a Singular Mission: Advancing Life Sciences Globally Through Specialized Language Solutions

Audio By Carbonatix

BOSTON--(BUSINESS WIRE)--Jun 9, 2025--

Today marks the official launch of Sesen, a next-generation language services company purpose-built to meet the complex demands of the life sciences industry. Specializing exclusively in translation, localization, and AI-enhanced linguistic solutions for pharmaceutical, biotechnology, medical device, CRO, and regulatory organizations, Sesen combines industry expertise with cutting-edge technology to deliver fast, accurate, and fully compliant multilingual communications across 150+ languages.

Built by industry veterans, Sesen is redefining how life sciences companies manage language workflows, from clinical trial documentation and regulatory labeling to patient communications and digital health platforms. At the core of its offering is SesenGPT, a proprietary AI engine trained on life sciences terminology and optimized for medical and regulatory content.

Key Capabilities Include:

• Regulatory-compliant translations aligned with EMA, FDA, and PMDA guidelines
• ISO 17100, ISO 9001:2015, and ISO 13485:2016 certified quality management
• AI-enabled hybrid workflows for clinical trial translations, pharmacovigilance, and labeling
• Native linguists and MD/PhD medical reviewers for domain-specific accuracy
• Scalable language solutions integrated with sponsor CMS and eTMF systems

“Life sciences innovation is increasingly global, but language remains a critical barrier,” said Dr. Vladimir Misik, VP of Global Clinical Trial Strategy. “We launched Sesen to solve this challenge with unmatched specialization, seamless technology integration, and the linguistic precision this industry demands.”

Diego Di Leva, Sesen’s VP of Global Operations, and a certified ISO 9001 and ISO 13485 auditor, added:

"At Sesen, language quality is not an afterthought, it’s built into the DNA of every project. Our quality assurance framework is grounded in international standards and supported by linguists with deep domain expertise, ensuring every deliverable meets the highest regulatory and scientific expectations."

With a growing network of linguists, in-country reviewers, and regulatory consultants, Sesen supports top pharmaceutical and biotechnology companies with on-time, compliant delivery of multilingual assets for product launches, clinical trials, and regulatory submissions.

About Sesen

Sesen is a specialized language solutions provider exclusively serving the life sciences industry. Focused on clinical, regulatory, and commercial translation, Sesen supports pharmaceutical, biotech, medical device, and CRO clients in 150+ languages. The company combines native linguists, medical professionals, and ISO-certified workflows with proprietary AI technology to deliver faster, more accurate, and compliant content. From clinical trial support to product localization, Sesen enables life sciences organizations to operate with linguistic confidence and regulatory precision. www.sesen.com

View source version on businesswire.com:https://www.businesswire.com/news/home/20250609939256/en/

CONTACT: Media Contact:

Nikki Andrews

[email protected]

KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY TECHNOLOGY FDA OTHER COMMUNICATIONS HEALTH PHARMACEUTICAL COMMUNICATIONS HEALTH TECHNOLOGY MEDICAL DEVICES ARTIFICIAL INTELLIGENCE CLINICAL TRIALS

SOURCE: Sesen

Copyright Business Wire 2025.

PUB: 06/09/2025 11:04 AM/DISC: 06/09/2025 11:03 AM

http://www.businesswire.com/news/home/20250609939256/en